Field evaluation of a novel preservation medium to transport sputum specimens for molecular detection of Mycobacterium tuberculosis in a rural African setting
- 16 May 2016
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 21 (6), 776-782
- https://doi.org/10.1111/tmi.12701
Abstract
To assess the performance of an innovative method of transporting sputum to centralized facilities for molecular detection of M. tuberculosis: using a swab to inoculate sputum in a transport medium, PrimeStore(®) Molecular Transport Medium (PS-MTM).Two sputum specimens were obtained from suspected tuberculosis (TB) patients at rural healthcare facilities in South Africa. A swab taken from each specimen and placed into PS-MTM, prior to it being processed by either liquid culture or Xpert MTB/Rif assay (Xpert).141 patients (including 47 with laboratory-confirmed TB) were included in this analysis. M. tuberculosis was detected at 29% by culture and 29% by Xpert, whereas 31% tested positive by IS6110 real-time PCR of PS-MTM from the culture and and 36% from the Xpert-paired specimen. Concordance between the method under evaluation with culture was 82% (McNemar, p=0.55) and 84% (McNemar, p=0.05) for Xpert. Stratified by culture result, the detection rate by IS6110 real-time PCR of PS-MTM was similar to Xpert for patients with positive culture (p=0.32), but significantly higher if culture was negative (p=0.008).These results suggest that swab collection of sputum into PS-MTM for transport is a promising method for diagnosis of TB in rural healthcare settings thereby potentially improving the options available for molecular diagnosis of TB in countries incapable of applying decentralized high-tech molecular testing. This article is protected by copyright. All rights reserved.Keywords
Funding Information
- University of Pretoria
This publication has 23 references indexed in Scilit:
- Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care testThe Lancet Infectious Diseases, 2013
- The Impact and Cost of Scaling up GeneXpert MTB/RIF in South AfricaPLOS ONE, 2012
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Comparison of the Xpert MTB/RIF Test with an IS 6110 -TaqMan Real-Time PCR Assay for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory SpecimensJournal of Clinical Microbiology, 2011
- Tuberculosis drug resistance testing by molecular methods: Opportunities and challenges in resource limited settingsJournal of Microbiological Methods, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Molecular diagnostic tools in mycobacteriologyJournal of Microbiological Methods, 2008
- Simplified detection of Mycobacterium tuberculosis in sputum using smear microscopy and PCR with molecular beaconsJournal of Medical Microbiology, 2007
- The success and failure of BCG — implications for a novel tuberculosis vaccineNature Reviews Microbiology, 2005
- Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reactionResearch in Microbiology, 1994